Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Asthma with permanent obstructive ventilation disorder].

J Lacronique1

  • 1Service de pneumologie, hôpital Cochin, Paris.

La Revue Du Praticien
|December 1, 1992
PubMed
Summary

Asthma with chronic airways obstruction (CAO) presents diagnostic challenges. Bronchodilator and corticosteroid tests, along with peak flow monitoring, help manage this condition and explore alternatives to systemic corticosteroids.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Welcome, Ch'tis!].

Revue de pneumologie clinique·2013
Same author

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.

The European respiratory journal·2012
Same author

[Eosinophilic pleural effusion related to taking valproic acid].

Revue de pneumologie clinique·2011
Same author

[Carte blanche to Brest Hospital: venous thromboembolism].

Revue de pneumologie clinique·2008
Same author

[Primum non nocere...inhaled glucocorticosteroids in 2003].

Revue de pneumologie clinique·2003
Same author

[Characteristics and specificities of cystic fibrosis in adults: evolutive disease of childhood or recently diagnosed disease?].

Revue des maladies respiratoires·2000

Area of Science:

  • Pulmonology
  • Clinical Medicine

Context:

  • Asthma with chronic airways obstruction (CAO) is a common and complex clinical issue.
  • Persistent airway inflammation is the primary driver of obstruction in this condition.
  • Distinguishing CAO in asthma from non-asthmatic chronic obstructive lung disease relies on respiratory function tests.

Purpose:

  • To explore diagnostic and management strategies for asthma with CAO.
  • To evaluate the role of pharmacological tests in assessing bronchomotor and inflammatory components of CAO.
  • To highlight the importance of peak flow monitoring and the search for corticosteroid alternatives.

Summary:

  • Pharmacological tests with bronchodilators assess the bronchomotor component of CAO, which is significant in asthma.
  • A negative bronchodilator test suggests predominant bronchial inflammation, making corticosteroid reversibility tests valuable.
  • Peak flow curves aid in monitoring CAO progression and patient education.
  • Severe chronic asthma necessitates careful management, including reducing systemic corticosteroid use.

Impact:

  • Improved diagnostic accuracy for asthma with CAO.
  • Enhanced patient monitoring and education through peak flow curve analysis.
  • Informed clinical decisions regarding bronchodilator and corticosteroid testing.
  • Provides rationale for developing novel anti-inflammatory therapies for severe asthma.

Related Experiment Videos